Johnson & Johnson says proposed opioid settlement to lower reported third-quarter profit by $3 billion

Johnson & Johnson on Wednesday lowered its previously reported profit for the third quarter to $1.8 billion from $4.8 billion to account for a proposed opioid settlement payment.